Systematic assessment of transcriptomic and phenotypic biological profiling for mechanism-based hazard assessment using target-annotated reference chemicals in renal proximal tubular epithelial cells
Integrating high-throughput in vitro data into next-generation risk assessment (NGRA) workflows requires screening strategies that yield quantitative potency estimates and mechanistically interpretable biological signals. Transcriptomic and morphological profiling are increasingly adopted for early-stage hazard identification by enabling triage of substances for resource-intensive follow-up and prioritizing candidates most likely to present meaningful risk. In this study, we aimed to characterize biological concordance and uncertainty by quantifying how well high-throughput transcriptomics (HTTr) and Cell Painting PLUS (CPP) bioactivity profiles recover target-relevant biological signals in immortalized human renal proximal tubule epithelial RPTEC/TERT1 cells using 313 reference chemicals with high-confidence target annotations. Through quality control procedures and biological activity filters we yielded 142 reference chemicals spanning 66 different targets, which were systematically evaluated for biological concentration-responses by HTTr and CPP. HTTr was evaluated using TXG-MAPr-based qualitative and quantitative gene network activity analysis. HTTr showed the most prominent activity for targets that were highest expressed in RPTEC/TERT1 cells. Active chemical-pairs showed strong gene network activity correlation albeit with different potencies. Similarly, the highest transcriptomic concordance was observed for reference chemicals acting in the same pathway, such as EGFR/MEK or PI3K/AKT/mTOR. CPP often showed high sensitivity primarily at the organelle level providing limited mechanistic insight for chemical grouping. Collectively, the results support HTTr and CPP as complementary early-tier assays within an in vitro weight-of-evidence safety testing framework. Although CPP is suitable as a cost-effective screening modality, HTTr offers higher mechanistic resolution for mode-of-action inference in high-throughput bioactivity screening and therefore remains necessary for high-confidence mechanistic interpretation.
Authors
- Giulia Callegaro (ORCID: https://orcid.org/0000-0002-7627-7271)
- Gerhard Franz Ecker (ORCID: https://orcid.org/0000-0003-4209-6883)
- Joshua Harrill (ORCID: https://orcid.org/0000-0003-4317-6391)
- Michael Oelgeschläger (ORCID: https://orcid.org/0000-0002-5787-5540)
- Bob van de Water (ORCID: https://orcid.org/0000-0002-5839-2380)
- Palle Steen Helmke (ORCID: https://orcid.org/0009-0003-8393-9047)
- Hugo W van Kessel (ORCID: https://orcid.org/0000-0001-9794-6385)
- Stephen Ferguson (ORCID: https://orcid.org/0000-0003-3172-8347)
- Shu Liu (ORCID: https://orcid.org/0000-0002-2904-0271)
- Marlene Wedler (ORCID: https://orcid.org/0009-0004-4702-1324)
- Dace Zigure (ORCID: https://orcid.org/0009-0003-1816-5815)
Institutions
- Leiden University (NL)
- University of Vienna (AT)
- German Federal Institute for Risk Assessment (BfR) (DE)
- National Institute of Environmental Health Sciences (US)
- Latvijas Organiskās Sintēzes Institūts (LV)
- Corteva (United States) (US)
- Freie Universität Berlin (DE)
Publication Details
- Journal
- Archives of Toxicology
- Published
- 2026-10-31
- DOI
- https://doi.org/10.1007/s00204-026-04612-8
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00